Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finerenone in Diabetic Kidney Disease
NCT02540993Phase 3Completed
- Sponsor
- Bayer
- Start
- Sep 2015
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 48
01
Overview
A Phase 3 trial of finerenone in diabetic kidney disease (DKD), sponsored by Bayer. Started Sep 2015; status: completed.
02
Drugs
finerenone
03
Conditions
diabetic kidney disease (DKD)
Beyond the preview
Go deeper on NCT02540993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02540993.